Movement Alert｜Oscar Health, Inc. Overnight Rise 5.18%, UBS Lifts Price Target While Saying Q3 Upside May Be Limited

Market Focus12:26

On November 4, Oscar Health, Inc. posted an Overnight rise of 5.18%, trading at $34.16 per share, with turnover of $40.41 million.

The main disclosed catalyst was a recent broker update that raised the price target to $36 from $26 while maintaining a neutral stance, alongside higher 2026-2028 EPS estimates.

In the supporting note ahead of the company’s November 5 earnings release, the broker said Oscar Health, Inc.’s updated guidance already reflects favorable medical utilization trends, reducing the likelihood of a large Q3 upside surprise even as operating performance improves. The firm lifted its 2026-2028 EPS forecasts to $2.00, $2.30, and $2.80, respectively. At the same time, it flagged that additional program integrity reviews affecting a large member cohort and possible disenrollment could weigh on revenue, although management indicated the effect could be absorbed within existing outlook assumptions.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment